News

A county-level study of COVID-19 vaccination rates by the US Centers for Disease Control and Prevention (CDC) reveals substantially lower rates in rural than in urban areas in the US.

Patients with moderate to severe pneumonia associated with COVID-19 and high C-reative protein levels may benefit from treatment with the monoclonal antibody tocilizumab, a follow-up study found.

A prospective study suggest co-infections and secondary infections are infrequent among COVID-19 patients, warranting the need for improved stewardship.

Mice treated with diABZI showed reduced weight loss and reduced viral load in the lungs and nostrils.

Maintaining non-pharmaceutical interventions were seen to reduce the spread of infections during computer modeling.

No evidence of an association between genetically predicted vitamin D levels and COVID-19 susceptibility were found in the study.

This is the first oral non-azole treatment for vaginal yeast infections.

Analysis of medications used in California hospitals over the course of 2020 highlights “evidence-based decisions.”

Younger participants in the study had a higher percentage of stokes than seen in the general population.

Worries mount in Africa as only 2% of the population has received a vaccine.

If it is approved, this would be the first new antifungal class in the United States in years.

During the COVID-19 surge last year, the federal government stopped the required reporting on healthcare-associated infections (HAI) thus leaving an absence of data and important information on HAI. One study examined the effect the initial pandemic surge had on Clostridioides Difficile infection (CDI) in one hospital.

Do the very freedoms Americans enjoy allow us to make less than optimal choices? And will it prevent us from doing what medical science says is best if needed again?

New research from Emory show a significant difference in institutional antibiotic prescribing after education on the value of PCT testing in infected patients last year.

An assessment of the frontline agents show similarities infection cure and recurrence rates at 30 days.

Rates of acute myocardial infarction were higher in those with genetic risks for familial hypercholesterolemia.

Patients with hypoxemia or tachypnea had an overall greater mortality risk compared to those without them.

Participants with a prior case of disease showed cells in their bone marrow up to 4 months after their initial infection.

Sotrovimab was developed by GlaxoSmithKline and Vir Biotechnology to treat mild-to-moderate disease in adults and pediatric patients.

Study of biomarkers of epigenetic aging in patients with HIV finds antiretroviral therapy partially reverses the accelerated aging associated with the infection.

The study authors looked at previously published papers focused on carbapenems, fluoroquinolones, and third-generation cephalosporins.

Reports of myocarditis were reported in mostly young adult males, 4 days after administration.

Lower levels of testosterone in the blood were also associated with increased inflammation.

Nearly half of COVID-19 patients never received rehabilitation evaluation and 20% lost daily living abilities.

Early treatment with lenzilumab improved the likelihood of survival without ventilation by 54% among patients hospitalized with COVID-19 who were hypoxic but not on invasive mechanical ventilation, a new study found.

The guidelines were welcomed by some, but infectious disease providers say caution is needed moving forward.

India pushes 300,000 COVID-19 death mark as worries of black fungus loom.

A discussion on issues surrounding the treatment of HIV with Melissa Badowski, PharmD, MPH.